Financial giants have made a conspicuous bearish move on Vertex Pharmaceuticals ... Money on the Move Benzinga Edge's Unusual Options board spots potential market movers before they happen.

Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...

Financial giants have made a conspicuous bearish move on Vertex Pharmaceuticals ... Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions ...

To put it mildly, last Tuesday was a “stressful day” for state Medicaid staff across the country, a former Medicaid director ... to cover Vertex’s pain drug Vertex Pharmaceuticals received ...

U.S. President Donald Trump has repeatedly mentioned pharmaceuticals as another industry that could be targeted by tariffs, ...

HAPPY BIRTHDAY — to David Edelman, Ropes & Gray’s Abby Cable; former Gov. Charlie Baker senior adviser and the NCAA’s Tim ...

L-R standing: BC Board of Trustees chairman John Fish ... Today, she serves as senior director of employee relations at Vertex Pharmaceuticals, one of the nation’s leading biotechnology companies. As ...

Pursuant to requirement of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform you that Akums Drugs & ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $470.37, demonstrating a +1.88% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...